Examining the RSL's Support for DVA Medicinal Cannabis Restrictions
The RSL has issued a media release welcoming DVA's Updated Medicinal Cannabis Framework. As an organisation serving veterans who depend on medicinal cannabis for chronic pain management, we believe this position merits thoughtful examination.
What does the evidence actually show?
- Clinical data from 493 veteran patients demonstrates:
- 77% report significant pain reduction
- 77% reduced or ceased opioid use
- 74% report improved mood and mental health
- 38.3% improvement in DASS-21 scores (depression, anxiety, stress)
- 21.1% reduction in suicide risk indicators
What did DVA measure before implementing restrictions?
According to Freedom of Information request LEX 76655: Nothing. DVA has never surveyed veteran patients, never consulted clinics managing large veteran cohorts, never tracked clinical outcomes, and never measured efficacy or adverse events.
What does the Updated Framework actually do?
It mandates in-person consultations in a system where:
- Only a fraction of ~32,000 VR GPs are TGA Authorised Prescribers
- Geographic analysis shows entire regions have zero accessible prescribers
- Veterans using THC cannot legally drive to mandatory appointments
- Rural veterans face insurmountable access barriers
What about the international comparison?
DVA claims alignment with Canada. Yet Canada removed specialist barriers in 2014 (DVA is adding them), embraces Telehealth for 27,000+ veterans (DVA bans it), covers PTSD explicitly (DVA excludes mental health), and invests $20M+ in research (DVA collects zero patient data).
These are not minor discrepancies. These are fundamental misalignments.
The RSL's endorsement raises important questions:
Did the RSL request the clinical outcomes data that DVA failed to collect? Did the RSL consult veterans currently using medicinal cannabis about the practical implications of mandatory in-person requirements? Did the RSL verify DVA's claims about international alignment?
Or did the RSL simply endorse a government framework without independent scrutiny?
Organisations representing veterans have a responsibility to interrogate policy changes against evidence - particularly when those changes restrict access to treatment that demonstrably works.
We believe veterans deserve advocacy grounded in clinical outcomes, not institutional alignment with administrative convenience.